Bosutinib Active Not Recruiting Phase 4 Trials for Previously Treated PH + CML Treatment

IndicationsStatusPurposePhase
Active Not RecruitingTreatment4
clinicaltrials.gov IdentifierTitleDrugs
NCT02228382Safety And Efficacy Study Of Bosutinib In Patients With Philadelphia Chromosome Positive Chronic Myeloid Leukemia Previously Treated With One Or More Tyrosine Kinase Inhibitors